Public Health England has commissioned the National Guideline Centre (NGC) to produce an evidence review of the literature on dependence, short term discontinuation and longer term withdrawal symptom from prescribed medicines, and their prevention and treatment.
The NGC is inviting stakeholders to submit research data or reports on two key areas to inform the review:
A) Collations of patients’ experi ences of the harms caused by prescribed medicines and ability to access and engage in treatment specifically relating to dependence, short term discontinuation or longer term withdrawal symptoms from the following prescribed medicines: opioids for chronic pain (excluding end of life /palliative care/cancer pain), benzodiazepines, Z-drugs, gabapentin and pregabalin (excluding epilepsy treatment), and antidepressants.…
Read more of this article
he Global Alliance for Musculoskeletal Health wishes to bring to your attention a series of papers published in a supplement of the European Spine Journal this month. They have been written by the Global Spine Care Initiative (GSCI), a sub group of World Spine Care, which in turn is a project of GMUSC.
On 6 September 2018, The European League Against Rheumatism (EULAR) published an update to a set of recommendations for the management of hand osteoarthritis. The recommendations report on new evidence made since a first EULAR report was published in 2007.
New dates from the British Medical Acupuncture Society.

Guest blog by Professor Anthony Woolf, Chair, ARMA
September 2018 has been declared International Pain Awareness Month by the International Association of Patient organizations (IAPO).
